These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 3918958)
1. [Oral glucocorticosteroid therapy in psoriasis vulgaris: pro and con]. Zaun H Hautarzt; 1985 Jan; 36(1):13-5. PubMed ID: 3918958 [TBL] [Abstract][Full Text] [Related]
2. Treatment of psoriasis. Bryant BG Am J Hosp Pharm; 1980 Jun; 37(6):814-20. PubMed ID: 6994496 [TBL] [Abstract][Full Text] [Related]
3. [Local treatment of psoriasis with glucocorticosteroids]. Marghescu S Hautarzt; 1985 Jan; 36(1):47-9. PubMed ID: 3972579 [TBL] [Abstract][Full Text] [Related]
4. [Photochemotherapy (PUVA): pro and con]. Wolff K Hautarzt; 1985 Jan; 36(1):25-33. PubMed ID: 3918959 [TBL] [Abstract][Full Text] [Related]
5. [Internal treatment of psoriasis--a review]. Zachariae H Hautarzt; 1976 Dec; 27(12):569-73. PubMed ID: 795794 [TBL] [Abstract][Full Text] [Related]
6. Topical therapy for the management of childhood psoriasis: part I. Cordoro KM Skin Therapy Lett; 2008 Apr; 13(3):1-3. PubMed ID: 18506356 [TBL] [Abstract][Full Text] [Related]
7. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists. Katz HI J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188 [TBL] [Abstract][Full Text] [Related]
9. [Dithranol and combined treatment procedures: pro and con]. Mahrle G; Schulze HJ; Steigleder GK Hautarzt; 1985 Jan; 36(1):34-9. PubMed ID: 3972577 [TBL] [Abstract][Full Text] [Related]
10. Generalized pustular psoriasis induced by systemic glucocorticosteroids: four cases and recommendations for treatment. Brenner M; Molin S; Ruebsam K; Weisenseel P; Ruzicka T; Prinz JC Br J Dermatol; 2009 Oct; 161(4):964-6. PubMed ID: 19681858 [No Abstract] [Full Text] [Related]
11. Therapeutic options in the treatment of psoriasis and atopic dermatitis. Gottlieb AB J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S3-16. PubMed ID: 15968262 [TBL] [Abstract][Full Text] [Related]
12. Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids. Mortimer KJ; Tattersfield AE Immunol Allergy Clin North Am; 2005 Aug; 25(3):523-39. PubMed ID: 16054541 [TBL] [Abstract][Full Text] [Related]
15. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis. Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961 [TBL] [Abstract][Full Text] [Related]
16. [Suggestions for therapy with glucocorticosteroids in obstructive airways diseases (author's transl)]. Meister W Z Erkr Atmungsorgane; 1978 Apr; 151(1):55-62. PubMed ID: 716494 [TBL] [Abstract][Full Text] [Related]
17. Methotrexate and other chemotherapeutic agents used to treat psoriasis. Jeffes EW; Weinstein GD Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891 [TBL] [Abstract][Full Text] [Related]
19. Calcipotriol. A new topical antipsoriatic. Kragballe K; Iversen L Dermatol Clin; 1993 Jan; 11(1):137-41. PubMed ID: 8435908 [TBL] [Abstract][Full Text] [Related]
20. [Current knowledge on the pathogenesis of common psoriasis as the basis for a scientifically founded therapy. II. Therapeutic possibilities and pathogenetic principles of antipsoriatic drugs]. Sönnichsen N; Haustein UF; Kluge K; Meffert H Dtsch Gesundheitsw; 1970 Jul; 25(28):1293-300. PubMed ID: 4933541 [No Abstract] [Full Text] [Related] [Next] [New Search]